Patents by Inventor Stephen Swanson

Stephen Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR DATA REPLICATION SYNCHRONIZATION
    Publication number: 20240095259
    Abstract: Systems and methods are provided for storing a first data object comprising a first set of immutable components, the first data object being associated with a corresponding second data object stored by a remote replication system. A difference is determined between the first set of immutable components of the first data object and a second set of immutable components of the corresponding second data object. A subset of immutable components is identified from the first set of immutable components based on the difference. The subset of immutable components from the first set of immutable components is provided to the remote replication system over a communication network.
    Type: Application
    Filed: November 28, 2023
    Publication date: March 21, 2024
    Inventors: Stephen Freiberg, Alexander Landau, Andrew Greene, Brian Dorne, Bryan Offutt, Ernest Zeidman, Ilya Nepomnyaschchiy, John Garrod, Katherine Brainard, Kolin Purcell, Michael Levin, Simon Swanson, Spencer Stecko
  • Compounds alpha v beta 6 integrin antagonists
    Patent number: 10004724
    Abstract: A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: June 26, 2018
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, Seble Lemma, Simon John Fawcett MacDonald, John Martin Pritchard, Panayiotis Alexandrou Procopiou, Stephen Swanson
  • NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
    Publication number: 20170290818
    Abstract: A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 22, 2015
    Publication date: October 12, 2017
    Inventors: Niall Andrew ANDERSON, Matthew Howard James CAMPBELL-CRAWFORD, Ashley Paul HANCOCK, Seble LEMMA, Simon John Fawcett MACDONALD, John Martin PRITCHARD, Panayiotis Alexandrou PROCOPIOU, Stephen SWANSON
  • COORDINATED PHYSICAL AND SENSORY TRAINING
    Publication number: 20170229041
    Abstract: Physical and/or sensory skills may be trained by varying the quantity of sensory information available to an individual, the quality of sensory information available to an individual, and/or the difficulty of physical training performed by an individual. The difficulty of training may be varied using eyewear that alters the quality/quantity of visual information available and/or that provide a display that instructs the individual training to increase/decrease the difficulty of training tasks. The difficulty of training may be varied in response to measurements of the physiology and/or performance of an individual training.
    Type: Application
    Filed: August 7, 2015
    Publication date: August 10, 2017
    Applicant: Instinct Performance LLC
    Inventors: Alan REICHOW, Stephen SWANSON
  • Fused heteroaryl derivatives and their use as p38 kinase inhibitors
    Patent number: 7750026
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: July 6, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Vipulkumar Kantibhai Patel, Stephen Swanson
  • Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
    Patent number: 7687532
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: March 30, 2010
    Assignee: GlaxoSmithkline LLC
    Inventors: Sebastien Andre Campos, Stephen Swanson, Ann Louise Walker
  • Fused heteroaryl derivatives for use as P38 kinase inhibitors
    Patent number: 7642276
    Abstract: Compounds of formula (I): wherein A is a 5-membered heteroaryl ring are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38, such as rheumatoid arthritis.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: January 5, 2010
    Assignee: SmithKline Beecham Corporation
    Inventors: Richard Martyn Angell, Ian Robert Baldwin, Paul Bamborough, Nigel Marc Deboeck, Timothy Longstaff, Stephen Swanson
  • Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
    Patent number: 7622464
    Abstract: Compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents —(CRnaRnb)n—; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5; R2 represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl; R3 and R4 each independently represent hydrogen or C1-6-alkyl; R7 represents hydrogen or C1-6alkyl; R8 represents hydrogen or C1-6alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: November 24, 2009
    Assignee: Glaxo Group Limited
    Inventors: Rachael Ann Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Martin Alistair Hayes, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Gail Mills, Graeme Michael Robertson, Stephen Swanson, Andrew John Walker, Mark Wilkinson
  • Biphenyl carboxylic amide p38 kinase inhibitors
    Patent number: 7572790
    Abstract: Compound of formula (I): or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: August 11, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Nicola Mary Aston, Paul Bamborough, Katherine Louise Jones, Vipulkumar Kantibhai Patel, Stephen Swanson, Ann Louise Walker
  • Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors
    Publication number: 20090023725
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: January 27, 2005
    Publication date: January 22, 2009
    Inventors: Paul Bamborough, Sebastien Andre Campos, Vipulkumar Kantibhai Patel, Stephen Swanson, Ann Louise Walker
  • Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
    Patent number: 7425555
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: September 16, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Richard Martyn Angell, Paul Bamborough, Ian Robert Baldwin, Anne-Marie Li-Kwai-Cheung, Timothy Longstaff, Suzanne Joy Merrick, Kathryn Jane Smith, Stephen Swanson, Ann Louise Walker
  • P38 kinase inhibitors
    Publication number: 20070161673
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: January 27, 2005
    Publication date: July 12, 2007
    Inventors: Michael Barker, Julie Hamblin, Katherine Jones, Vipulkumar Patel, Stephen Swanson, Ann Walker
  • Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
    Publication number: 20070142372
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: January 27, 2005
    Publication date: June 21, 2007
    Inventors: Sebastien Campos, Stephen Swanson, Ann Walker
  • Biphenyl carboxylic amide p38 kinase inhibitors
    Publication number: 20070129354
    Abstract: Compound of formula (I): or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
    Type: Application
    Filed: April 7, 2004
    Publication date: June 7, 2007
    Inventors: Nicola Aston, Paul Bamborough, Katherine Jones, Vipulkumar Patel, Stephen Swanson, Ann Walker
  • Silicone rubber composition
    Publication number: 20070100072
    Abstract: A silicone rubber composition exhibiting superior adhesive properties with respect to organic resins it comes into contact with during its cure, while at the same time possessing superior mold release properties with respect to metal dies used for its molding, contains: (A) a polyorganosiloxane having at least two silicon-bonded alkenyl groups per molecule; (B) a polyorganosiloxane having at least two silicon-bonded hydrogen atoms per molecule; (C) an alkylene glycol ester of diacrylic acid or an alkylene glycol ester of dimethacrylic acid having the formula (1), wherein R1 is hydrogen or a methyl group, R2 represents an alkylene group, and n has a value of 1-10; and (D) a platinum catalyst.
    Type: Application
    Filed: July 19, 2004
    Publication date: May 3, 2007
    Inventors: Hiroshi Akitomo, Richard Cole, Michael Lutz, Stephen Swanson, Hyung Yang
  • Fused heteroaryl derivatives and their use as p38 kinase inhibitors
    Publication number: 20070054942
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: January 27, 2005
    Publication date: March 8, 2007
    Inventors: Vipulkumar Patel, Stephen Swanson
  • Compounds useful in the treatment of inflammatory diseases
    Patent number: 7157457
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: January 2, 2007
    Assignee: Glaxo Group Limited
    Inventors: Rachael Anne Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Graeme Michael Robertson, Stephen Swanson
  • Morpholin-acetamide derivatives for the treatment of inflammatory diseases
    Patent number: 7101882
    Abstract: The present invention relates to novel morpholin-acetamide compounds of formula (I) useful for the treatment of inflammatory diseases. Compounds of formula (I) wherein R1, R2, R3, R4, R5, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: September 5, 2006
    Assignee: Glaxo Group Limited
    Inventors: Rachael Anne Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Graeme Michael Robertson, Stephen Swanson
  • Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
    Publication number: 20060122221
    Abstract: Compounds of formula (I): wherein A is a 5-membered heteroaryl ring are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38, such as rheumatoid arthritis.
    Type: Application
    Filed: July 30, 2003
    Publication date: June 8, 2006
    Inventors: Richard Angell, Ian Baldwin, Paul Bamborough, Nigel Deboeck, Timothy Longstaff, Stephen Swanson
  • Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
    Publication number: 20060089393
    Abstract: Compounds of formula (I) are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Application
    Filed: April 29, 2003
    Publication date: April 27, 2006
    Inventors: Richard Angell, Paul Bamborough, Ian Baldwin, Anne-Marie Li-Kwai-Cheung, Timothy Longstaff, Suzanne Merrick, Kathryn Smith, Stephen Swanson, Ann Walker